SGHT Live signaler | Maksimer profitt med Getagraph.com

KJøP 117135 min ago

@ $4.25

Utstedt: 13 feb 2024 @ 15:30

Avkastning: 40.17%

Forrige signal: feb 7 - 15:30

Forrige signal: Selg

Avkastning: -3.36 %

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 22:00):

Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases...

Stats
Dagens volum	90 639.00
Gjennomsnittsvolum	165 096
Markedsverdi	296.49M
EPS	$0 ( 2024-05-02 )
Neste inntjeningsdato	( $-0.280 ) 2024-06-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-5.23
ATR14	$0.0170 (0.28%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-03	Hayden Jeremy B.	Sell	4 893	Common Stock
2024-04-03	Badawi Paul	Sell	12 571	Common Stock
2024-04-03	Badawi David	Sell	3 128	Common Stock
2024-04-03	Park Sam Boong	Sell	3 414	Common Stock
2024-04-03	Bauerlein Alison	Sell	10 123	Common Stock

INSIDER POWER
-23.78
Last 95 transactions
Buy: 4 792 402 \| Sell: 8 805 650

Volum Korrelasjon

Lang: 0.16 (neutral)

Kort: 0.87 (strong)

Signal:(64.621) Same movement expected

Sight Sciences, Inc. Korrelasjon

10 Mest positive korrelasjoner
COFS	0.925
LWAC	0.917
EM	0.911
STIM	0.903
PBYI	0.898
ESGR	0.888
RDVT	0.88
SDG	0.876
PPH	0.876
RVSB	0.873

10 Mest negative korrelasjoner
PLMR	-0.903
SRZN	-0.898
MRUS	-0.882
NEXI	-0.881
PAYO	-0.868
MTSL	-0.867
PRVA	-0.863
RMRM	-0.861
IMRX	-0.86
SVAC	-0.858

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Sight Sciences, Inc. Korrelasjon - Valuta/Råvare

-0.43
( neutral )

0.00
( neutral )

0.04
( neutral )

-0.24
( neutral )

0.53
( weak )

Sight Sciences, Inc. Økonomi

Annual	2023
Omsetning:	$81.06M
Bruttogevinst:	$69.18M (85.34 %)
EPS:	$-1.140

FY	2023
Omsetning:	$81.06M
Bruttogevinst:	$69.18M (85.34 %)
EPS:	$-1.140

FY	2022
Omsetning:	$71.33M
Bruttogevinst:	$58.97M (82.67 %)
EPS:	$-1.800

FY	2021
Omsetning:	$48.96M
Bruttogevinst:	$40.35M (82.41 %)
EPS:	$-2.36

Financial Reports:

No articles found.

Sight Sciences, Inc.

Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology for the treatment of dry eye disease (DED) for ophthalmologists and optometrists. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.